Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link

References

• Nurmohamed MT. Cardiovascular risk in rheumatoid arthritis. Autoimmunity Rev.8, 663–667 (2009).
   PubMed Web of Science ®Google Scholar
• Aviña-Zubieta J, Choi H, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum.59, 1690–1697 (2008).
   PubMed Web of Science ®Google Scholar
• Maradit-Kremers H, Crowson CS, Nicola PJ et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis. A population-based cohort study. Arthritis Rheum.50, 3444–3449 (2005).
   Google Scholar
• Shoenfeld Y, Gerli R, Doria A et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation112, 3337–3347 (2005).
   PubMed Web of Science ®Google Scholar
• van Halm VP, Peters MJ, Voskuyl AE et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease, a cross-sectional study: the CARRE investigation. Ann. Rheum. Dis.68, 1395–1400 (2009).
   PubMed Web of Science ®Google Scholar
• Peters MJ, van Halm VP, Voskuyl AE et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum.61, 1571–1579 (2009).
   PubMedGoogle Scholar
• Khan F, Galarraga B, Belch JJ. The role of endothelial function and its assessment in rheumatoid arthritis. Nat. Rev. Rheumatol.6, 253–261 (2010).
   Google Scholar
• Tyrrell PN, Beyene J, Feldman BM, McCrindle BW, Silverman ED, Bradley TJ. Rheumatic disease and carotid intima-media thickness. A systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol.30, 1014–1026 (2010).
   PubMed Web of Science ®Google Scholar
• Bergholm R, Leirisalo-Repo M, Vehkavaara S, Mäkimattila S, Taskinen MR, Yki-Järvinen H. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler. Thromb. Vasc. Biol.22, 1637–1641 (2002).
   PubMedGoogle Scholar
• Hannawi S, Marwick TH, Thomas R. Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res. Ther.11, R51 (2009).
   PubMed Web of Science ®Google Scholar
• Szodoray P, Szabó Z, Kapitány A et al. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev.9, 140–143 (2010).
   PubMed Web of Science ®Google Scholar
• Farragher TM, Goodson NJ, Naseem H et al. Association of HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum.58, 359–369 (2008).
   PubMed Web of Science ®Google Scholar
• Mattey DL, Thomson W, Ollier WER et al. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis. Arthritis Rheum.56, 1408–1416 (2007).
   Google Scholar
• Gonzalez-Gay MA, Gonzales-Juanatey C, Lopez-Diaz MJ et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum.57, 125–132 (2007).
   PubMedGoogle Scholar
• Gonzalez-Gay M, Gonzalez-Juanatey C, Ollier WE. Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles. Autoimmunity Rev.3, 301–304 (2004).
   PubMed Web of Science ®Google Scholar
• Panoulas VF, Stavropoulos-Kalinoglou A, Metsios GS et al. Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis204, 178–183 (2009).
   PubMed Web of Science ®Google Scholar
• Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR et al. Interleukin-6 gene-174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin. Exp. Rheumatol.27, 964–970 (2009).
   PubMed Web of Science ®Google Scholar
• Vallvé JC, Paredes S, Girona J et al. Tumor necrosis factor-α-1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis. J. Rheumatol.35, 1697–1703 (2008).
   PubMed Web of Science ®Google Scholar
• Gerli R, Sherer Y, Bocci EB, Vaudo G, Moscatelli S, Shoenfeld Y. Precocious atherosclerosis in rheumatoid arthritis. Role of traditional and disease-related cardiovascular risk factors. Ann. N. Y. Acad. Sci.1108, 372–381 (2007).
   PubMed Web of Science ®Google Scholar
• Gabriel SE. Heart disease and rheumatoid arthritis: understanding the risks. Ann. Rheum. Dis.69, i61–i64 (2009).
   Google Scholar
• Brady S, de Courten B, Reid CM, Cicuttini FM, de Courten MP, Liew D. The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J. Rheumatol.36, 34–40 (2009).
   PubMed Web of Science ®Google Scholar
• Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum.62, 369–377 (2010).
   PubMed Web of Science ®Google Scholar
• Baka Z, Buzàs E, Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res. Ther.11, 238 (2009).
   PubMed Web of Science ®Google Scholar
• Gerli R, Sherer Y, Vaudo G et al. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann. N. Y. Acad. Sci.1051, 281–290 (2005).
   PubMed Web of Science ®Google Scholar
• van Halm VP, Nielen MM, Nurmohamed MT et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann. Rheum. Dis.66, 184–188 (2007).
   PubMed Web of Science ®Google Scholar
• Steiner G, Urowitz M. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin. Arthritis Rheum.38, 372–381 (2009).
   PubMed Web of Science ®Google Scholar
• Rizzo M, Spinas GA, Cesur M, Ozbalkan Z, Rini GB, Berneis K. Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naive patients with early rheumatoid arthritis. Atherosclerosis207, 502–506 (2009).
   PubMed Web of Science ®Google Scholar
• Chung CP, Oeser A, Solus JF et al. Inflammation associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum.58, 2105–2112 (2008).
   PubMed Web of Science ®Google Scholar
• Panoulas VF, Douglas KM, Smith JP et al. Polymorphism of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium15, 203–212 (2008).
   PubMed Web of Science ®Google Scholar
• Panoulas VF, Douglas KM, Smith JP et al. Transforming growth factor-β1 869T/C, but not interleukin-6–174G/C, polymorphism associates with hypertension in rheumatoid arthritis. Rheumatology48, 113–118 (2009).
   PubMed Web of Science ®Google Scholar
• Ozbalkan Z, Efe C, Cesur M et al. An update on the relationship between rheumatoid arthritis and atherosclerosis. Atherosclerosis DOI: 10.1016/j.atherosclerosis.2010.03.035 (2010) (Epub ahead of print).
   Google Scholar
• Solomon D, Kremer J, Curtis J et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann. Rheum. Dis. DOI: 10.1136/ard.2009.122226 (2010) (Epub ahead of print).
   Google Scholar
• Ku IA, Imboden JB, Hsue PY, Ganz P. Rheumatoid arthritis-a model of systemic inflammation driving atherosclerosis. Circ. J.73, 977–985 (2009).
   PubMed Web of Science ®Google Scholar
• van Leuven S, Franssen R, Kastelein J, Levi M, Stroes E, Tak P. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology47, 3–7 (2008).
   PubMed Web of Science ®Google Scholar
• Montecucco F, Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis. Rheumatology48, 11–22 (2009).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay M, Gonzales-Juanatey C, Pineiro A, Garcia-Porrua C, Testa A, Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J. Rheumatol.32, 1219–1223 (2005).
   PubMed Web of Science ®Google Scholar
• Full LE, Ruisanchez C, Monaco C. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res. Ther.11, 217 (2009).
   PubMed Web of Science ®Google Scholar
• Rho YH, Chung CP, Oeser A et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum.61, 1580–1585 (2009).
   PubMed Web of Science ®Google Scholar
• Liang KP, Kremers HM, Crowson CS et al. Autoantibodies and the risk of cardiovascular events. J. Rheumatol.36, 2462–2469 (2009).
   Google Scholar
• Gerli R, Bartoloni Bocci E, Sherer Y, Vaudo G, Moscatelli S, Shoenfeld Y. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann. Rheum. Dis.67, 724–725 (2008).
   PubMedGoogle Scholar
• Sherer Y, Gerli R, Gilburd B et al. Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. Lupus16, 259–264 (2007).
   PubMedGoogle Scholar
• Pereira I, Laurindo I, Burlingame R et al. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis. Joint Bone Spine75, 416–421 (2008).
   PubMed Web of Science ®Google Scholar
• Ahmed HM, Youssef M, Mosaad YM. Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis. Clin. Rheumatol. DOI: 10.1007/s10067-010-1436-0 (2010) (Epub ahead of print).
   Google Scholar
• Liuzzo G, Biasucci LM, Trotta G et al. Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J. Am. Coll. Cardiol.50, 1450–1458 (2007).
   PubMed Web of Science ®Google Scholar
• Gerli R, Schillaci G, Giordano A et al. CD4+CD28null T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation109, 2744–2748 (2004).
   PubMed Web of Science ®Google Scholar
• Gerli R, Vaudo G, Bartoloni Bocci E, Schillaci G, Bistoni O, Shoenfeld Y. Different roles for anti-cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid arthritis: comment on the article by Farragher et al.Arthritis Rheum.60, 631–631 (2009).
   Google Scholar
• Werner N, Kosiol S, Schiegel T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med.353, 999–1007 (2005).
   PubMed Web of Science ®Google Scholar
• Van Zonneveld AJ, de Boer HC, van der Veer EP, Rabenlink TJ. Inflammation, vascular injury and repair in rheumatoid arthritis. Ann. Rheum. Dis.69, i57–i60 (2010).
   Google Scholar
• Distler JH, Beyer C, Schett G, Lüscher T, Gay S, Distler O. Endothelial progenitor cell. Novel players in the pathogenesis of rheumatic diseases. Arthritis Rheum.60, 3168–3179 (2009).
   Google Scholar
• Yiu KH, Wang S, Mok MY et al. Role of circulating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification. J. Rheumatol.37, 529–535 (2010).
   Google Scholar
• Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol.26, 112–116 (2006).
   PubMed Web of Science ®Google Scholar
• Khan F, Galarraga B, Belch JJ. The role of endothelial function and its assessment in rheumatoid arthritis. Nat. Rev. Rheumatol.6, 253–261 (2010).
   Google Scholar
• Tyrrell PN, Beyene J, Feldman BM, McCrindle BW, Silverman ED, Bradley TJ. Rheumatic disease and carotid intima-media thickness. A systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol.30, 1014–1026 (2010).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin. Arthritis Rheum.38, 366–371 (2009).
   PubMed Web of Science ®Google Scholar
• Bocci EB, Marchesi S, Delle Monache F et al. Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity. Reumatismo57, 16–21 (2005).
   Google Scholar
• Ristic G, Lepic T, Glisic B et al. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology49, 1076–1081 (2010).
   PubMed Web of Science ®Google Scholar
• Naranjo A, Sokka I, Descalzo MA et al. Cardiovascular disease in patients with rheumatoid arthritis: results from QUEST-RA study. Arthritis Res. Ther.10, R30 (2008).
   PubMed Web of Science ®Google Scholar
• Kerekes G, Soltèsz P, Dèr H et al. Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis. Ann. N. Y. Acad. Sci.1173, 814–821 (2009).
   Google Scholar
• Westlake S, Colebatch A, Baird J et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology49, 295–307 (2010).
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Johnston SS, John AK. The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. Curr. Med. Res. Opin.24, 469–480 (2008).
   PubMed Web of Science ®Google Scholar
• Georgiadis AN, Voulgari PV, Argyropoulou MI et al. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin. Arthritis Rheum.38, 13–19 (2008).
   PubMedGoogle Scholar
• Angel K, Aarrestad Provan S, Løvdahl Gulseth H, Mowinckel P, Kvien K, Atar D. Tumor necrosis factor-α antagonists improve aortic stiffness in patients with inflammatory arthropathies. A controlled study. Hypertension55, 333–338 (2010).
   PubMed Web of Science ®Google Scholar
• Gallaraga B, Belch JJ, Pullar T, Ogston S, Khan F. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. J. Rheumatol.37, 521–528 (2010).
   Google Scholar
• Turiel M, Tomasoni L, Sitia S et al. Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis. Cardiovascular Ther. DOI: 10.1111/j.1755-5922.2009.00119.x (2010) (Epub ahead of print).
   Google Scholar
• Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA. Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor α blocker therapy. Arthritis Rheum.59, 1821–1824 (2008).
   PubMed Web of Science ®Google Scholar
• Kerekes G, Soltsez P, Der H et al. Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis. Clin. Rheumatol.28, 705–710 (2009).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C et al. Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis. Clin. Exp. Rheum.24, 83–86 (2006).
   PubMed Web of Science ®Google Scholar
• Gerli R, Bocci EB, Shoenfeld Y. Effect of tumor necrosis factor α inhibition on CD28 surface expression on CD4+ T cells. Arthritis Rheum.54, 3060–3061 (2006).
   Google Scholar
• Gerli R. Vaudo G, Bocci EB et al. Functional impairment of arterial wall in primary Sjögren’s syndrome: combined action of immunological and inflammatory factors. Arthritis Care Res.62, 712–718 (2010).
   Google Scholar
• Peters MJ, Symmons DP, McCarey D et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann. Rheum. Dis.69, 325–331 (2010).
   PubMed Web of Science ®Google Scholar
• Bisoendial R, Stroes E, Kastelein J, Tak P. Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins. Nat. Rev. Rheumatol.6, 157–164 (2010).
   Google Scholar